Skip to Content

XR 150 (Quetiapine Fumarate Extended-Release 150 mg)

Pill with imprint XR 150 is White, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 150 mg. It is supplied by Par Pharmaceutical, Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; depression; schizophrenia; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for XR 150

Quetiapine fumarate extended-release 150 mg XR 150 Front
Quetiapine fumarate extended-release 150 mg XR 150 Back

Quetiapine Fumarate Extended-Release

XR 150
150 mg
17.00 mm
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, hypromelloses, magnesium stearate, polyethylene glycol 400, titanium dioxide, water

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
49884-0806 Par Pharmaceutical, Inc.
00310-0281 AstraZeneca
00310-8281 AstraZeneca

Get help with Imprint Code FAQs.

Related Images for "XR 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.